High-dose chemotherapy and autologous stem cell transplantation in treating paediatric malignancies

被引：1
|
作者：
Valteau-Couanet, D. [1 ]
Dufour, C. [1 ]
Hartmann, O. [1 ]
机构：
[1] Inst Gustave Roussy, Dept Pediat, F-94805 Villejuif, France
来源：
ONCOLOGIE | 2007年 / 9卷 / 12期
关键词：
high-dose chemotherapy; autologous stem cell transplantation; solid tumour; paediatrics;
D O I：
10.1007/s10269-007-0791-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Most paediatric malignancies can be cured with conventional chemotherapy. Autologous stem cell transplantation makes it possible to dramatically increase chemotherapy doses and cure tumours that were resistant to conventional chemotherapy, such as high-risk neuroblastoma and metastatic Ewing sarcoma. High-dose chemotherapy and autologous transplantation are major tools in treating patients who have very high-risk malignancies. In patients with brain tumours, it aims at improving prognosis and decreasing sequelae. Maintenance therapy has been developed to follow high-dose chemotherapy and treat minimal, persistent, residual disease.
引用
收藏
页码：827 / 831
页数：5
相关论文
共 50 条
  • [21] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA WITH RENAL FAILURE
    Pokrovskaya, O.
    Mendeleeva, L.
    Urnova, E.
    Firsova, M.
    Nareyko, M.
    Kuzmina, L.
    Rekhtina, I.
    Tauson, I.
    Varlamova, E.
    Parovichnikova, E.
    Savchenko, V.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S345 - S346
  • [22] Herpes zoster after high-dose chemotherapy and autologous stem cell transplantation.
    Fetscher, S
    Technau, K
    Lange, W
    BONE MARROW TRANSPLANTATION, 1999, 23 : S114 - S114
  • [23] RESULTS OF HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE TREATMENT OF MEDULLOBLASTOMA
    Gevorgian, A.
    Morozova, E.
    Kazantsev, I.
    Iukhta, T.
    Safonova, S.
    Punanov, Y.
    Afanasyev, B.
    Zheludkova, O.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S275 - S275
  • [24] High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancer
    P Bojko
    A Welt
    R Schleucher
    D Borquez
    M E Scheulen
    U Vanhoefer
    C Poettgen
    M Stuschke
    C E Broelsch
    G Stamatis
    H Wilke
    S Seeber
    A Harstrick
    Bone Marrow Transplantation, 2004, 34 : 637 - 643
  • [25] Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis
    Miyajima, Toru
    Ogasawara, Reiki
    Tsukamoto, Shihori
    Ishio, Takashi
    Yokoyama, Emi
    Izumiyama, Koh
    Mori, Akio
    Saito, Makoto
    Morioka, Masanobu
    Kondo, Takeshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (01) : 141 - 145
  • [26] High-dose chemotherapy and autologous blood stem cell transplantation in children with metastatic neuroblastoma
    Kai, T
    Ishii, E
    Matsuzaki, A
    Inaba, S
    Suita, S
    Ueda, K
    ACTA PAEDIATRICA JAPONICA, 1997, 39 (01): : 54 - 60
  • [27] High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Breast Cancer: Is There Still a Hope?
    Demirer, Taner
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2016, 26 (03): : 182 - 187
  • [28] Infectious complications after high-dose chemotherapy and autologous stem cell transplantation.
    Reich, G
    Mapara, MY
    Reichardt, P
    Dörken, B
    Maschmeyer, G
    BLOOD, 1998, 92 (10) : 337B - 337B
  • [29] High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    Gertz, Marie A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji K.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) : 343 - 360
  • [30] High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer
    Y. Tokuda
    Masatoshi Ohta
    Akira Okumura
    Soichi Kuge
    Mitsuhiro Kubota
    Tomoo Tajima
    Toshio Mitomi
    Cancer Chemotherapy and Pharmacology, 1997, 40 : S94 - S99
12345